Please login to the form below

Not currently logged in
Email:
Password:

influenza

This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.

Sanofi backs vaccines unit with €350m Canadian facility

Sanofi backs vaccines unit with €350m Canadian facility

Last year’s performance was driven by Sanofi’s paediatric and influenza vaccines, and the pharma company has also been investing in the latter category.

Latest news

More from news
Approximately 20 fully matching, plus 192 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    coli and influenza, and in toxicology applications. While Abbott already has a significant diagnostics presence with global sales in 2015 in this segment of $4.6bn, it forecasts that the acquisition

  • Another lost decade for research? Another lost decade for research?

    diseases that cause significant morbidity and mortality, such as influenza and malaria, but remain difficult to vaccinate against.

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    318. Novartis/CSL. Asset purchase. Influenza vaccines. 275. Five Prime/GSK. Expansion of collaboration.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.

  • Influenza

    Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.

More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics